Chat with us, powered by LiveChat

Gene Delivery Technologies Market (Delivery System - Viral Gene Delivery Systems, Non-viral Gene Delivery System, and Combined Hybrid Delivery Systems; Mode - AAV, Lentivirus, and Retrovirus; Application - Gene Therapy, Cell Therapy, Vaccines, and Research; Method - Ex Vivo, In Vivo, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

Gene Delivery Technologies Market (Delivery System - Viral Gene Delivery Systems, Non-viral Gene Delivery System, and Combined Hybrid Delivery Systems; Mode - AAV, Lentivirus, and Retrovirus; Application - Gene Therapy, Cell Therapy, Vaccines, and Research; Method - Ex Vivo, In Vivo, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

Report Code: IGR01189 Category: Healthcare & Medical Devices Published: August, 2023

A recent report published by Infinium Global Research on gene delivery technologies market provides in-depth analysis of segments and sub-segments in the global as well as regional gene delivery technologies market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional gene delivery technologies market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global gene delivery technologies market.

Market Insight:

The global gene delivery technologies market was valued at USD 3475.26 million in 2022 and is expected to reach USD 10812.92 million in 2030, with a CAGR 15.75% during the forecast period 2023-2030.

The act of transferring foreign genetic material, such as DNA or RNA, into host cells is known as gene delivery. It plays a crucial role in various scientific, medical, and biotechnological applications, including gene therapy, genetic engineering, and the study of gene function. Gene delivery systems can be categorized into two main types germline gene delivery systems and somatic gene delivery systems. Germline gene delivery systems involve introducing a section of DNA into cells that do not produce eggs or sperm. These cells can be found in different tissues throughout the body. The purpose of germline gene delivery is to affect the genetic makeup of the individual in a heritable manner. Moreover, somatic gene delivery systems, involve introducing a section of DNA into cells that produce eggs or sperm. The genetic modifications made through somatic gene delivery are not passed on to future generations but affect only the individual receiving the treatment.

The primary factor driving the growth of the market is increasing genetic and inherited diseases among the population. Moreover, the growing demand for targeted therapeutics is the significant factor that is driving the global market for gene-delivery technology during the forecast period. The factor which restrains the growth of the market is the adverse effect related to gene therapy, such as Immune Responses, Off-Target Effects, the toxicity of Delivery Vehicles, etc. Although, investment in Research and Development (R&D) is a crucial factor that presents a significant opportunity for the growth of the gene delivery technology market. By allocating resources and funding to R&D efforts focused on advancing gene therapy technologies and therapies, the market can experience substantial advancements and expansion.

Gene Delivery Technologies Market Size, Share, Trends | IGR

The gene delivery technologies market is segmented into North America, Europe, Asia Pacific, and the Row. North America is expected to hold a significant share of the gene delivery technologies market during the projected period. The rising presence of key players in the gene therapy field, including pharmaceutical companies, research institutions, and biotechnology firms, contributes to the region's leadership. Furthermore, the prevalence of chronic diseases in North America has created a demand for innovative treatment options such as gene therapies. On the other hand, the Asia Pacific region is projected to witness the fastest growth in the gene delivery technologies market. This can be attributed to several factors, including the region's large population, which presents significant market potential. Additionally, lower manufacturing and research costs in some countries within the Asia Pacific region make it an attractive destination for clinical trials. Moreover, the Europe region experiencing stable growth in the market has its own unique drivers. The region benefits from stringent government regulations that ensure patient safety and product efficacy. These regulations provide a favorable environment for gene delivery technology research and development, supporting market growth in Europe.

Report Scope of the Gene Delivery Technologies Market:

Report Coverage Details
Market Size in 2022 USD 3475.26 Million
Market Size by 2030 USD 10812.92 Million
Growth Rate from 2023 to 2030 CAGR of 15.75%
Largest Market North America
No. of Pages 300
Market Drivers
  • Increasing genetic and inherited diseases among the population drive the growth of the market.

  • The growing demand for targeted therapeutics propels the growth of the market.

Market Segmentation By Delivery System, By Mode, By Application, and By Method
Regional Scope North America, Europe, Asia Pacific, and RoW

Segment Covered

The report on global gene delivery technologies market covers segments such as delivery system, mode, application, and method. On the basis of delivery system, the sub-markets include viral gene delivery systems, non-viral gene delivery system, and combined hybrid delivery systems. On the basis of mode, the sub-markets include AAV, lentivirus, and retrovirus. On the basis of application, the sub-markets include gene therapy, cell therapy, vaccines, and research. On the basis of method, the sub-markets include ex vivo, in vivo, and others.

The report provides profiles of the companies in the gene delivery technologies market such as Thermo Fisher Scientific Inc., Oxford Biomedica, SignaGen Laboratories, Synbio Technologies, SIRION Biotech, Novartis AG, Bio-Rad Laboratories, Inc, OriGene Technologies, Inc., Promega Corporation, and Others.

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the gene delivery technologies market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Frequently Asked Questions (FAQ's)

The global gene delivery technologies market was valued at USD 3475.26 Million in 2022.
It is likely to grow at a CAGR of 15.75% during the forecast period 2023-2030.
The global gene delivery technologies market is estimated to reach USD 10812.92 Million by the end of 2030.
North America is anticipated to exhibit high demand for gene delivery technologies market during the forecast period.
Thermo Fisher Scientific Inc., Oxford Biomedica, SignaGen Laboratories, Synbio Technologies, SIRION Biotech, Novartis AG, Bio-Rad Laboratories, Inc, OriGene Technologies, Inc., Promega Corporation, and Others.
CHOOSE LICENCE TYPE

Please Choose One of them.

Google translate
© 2024. Infinium Global Research LLP. All Rights Reserved.